DES Oncologie Toulouse

Le site du DES d'oncologie de Toulouse

Contact

Pour l'oncologie médicale :

Maëva Bonneau

maevabonneau16@gmail.com

Pour la Radiothérapie :

Corentin Pasquier

pasquier.corentin@iuct-oncopole.fr

RESUME PORTEC 2

Corentin Pasquier24/01/2022

Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial

maeva bonneau20/01/2022

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

maeva bonneau20/01/2022

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

maeva bonneau20/01/2022

European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

Guillaume Roces27/12/2021

Tout afficher